Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ASC30

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity

Ascletis Pharma (China) Co · Phase 1 · Completed · Enrollment 72

NCT06680440

ArmPopulationDoseWeeksEstimandWeight change
SAD Cohort 1Obesity or overweightn/rn/rn/rn/r
SAD Cohort 2Obesity or overweightn/rn/rn/rn/r
SAD Cohort 3Obesity or overweightn/rn/rn/rn/r
SAD Cohort 4Obesity or overweightn/rn/rn/rn/r
SAD Cohort 5Obesity or overweightn/rn/rn/rn/r
MAD Cohort 1Obesity or overweightn/rn/rn/rn/r
MAD Cohort 2Obesity or overweightn/rn/rn/rn/r
MAD Cohort 3Obesity or overweightn/rn/rn/rn/r